Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01576185 · ClinicalTrials.gov registry record
Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid Leukemia
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 10
- Enrollment target
NCT01576185 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 10 participants.
The verdict
NCT01576185 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
These laboratory trial studies the development and treatment of a mouse model for acute myeloid leukemia (AML) using samples from younger patients with AML. Studying tissue samples from patients with cancer in the laboratory may help doctors learn more about cancer and how well patients will respond to treatment.
Interventions
- OTHER laboratory biomarker analysis
- DRUG sorafenib tosylate
- DRUG quizartinib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01576185
The ClinicalTrials.gov registry entry for NCT01576185 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT01576185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01576185 about?
NCT01576185 is a clinical study titled "Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid Leukemia". These laboratory trial studies the development and treatment of a mouse model for acute myeloid leukemia (AML) using samples from younger patients with AML. Studying tissue samples from patients with cancer in the laboratory may help doctors learn more about cancer and how well patients will respond...
What is the current status of trial NCT01576185?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2012-05. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01576185?
The interventions under investigation include: laboratory biomarker analysis (OTHER), sorafenib tosylate (DRUG), quizartinib (DRUG).
Who is sponsoring clinical trial NCT01576185?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.